These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The politics of buzzwords at the interface of technoscience, market and society: the case of 'public engagement in science'. Bensaude Vincent B Public Underst Sci; 2014 Apr; 23(3):238-53. PubMed ID: 24495899 [TBL] [Abstract][Full Text] [Related]
26. A precautionary principle for dual use research in the life sciences. Kuhlau F; Höglund AT; Evers K; Eriksson S Bioethics; 2011 Jan; 25(1):1-8. PubMed ID: 19594724 [TBL] [Abstract][Full Text] [Related]
27. Innovation for life science innovators. Cancer Discov; 2012 Dec; 2(12):OF1. PubMed ID: 23230190 [TBL] [Abstract][Full Text] [Related]
28. Options for a rational dialogue on the acceptance of biotechnology. von Grebmer K; Omamo SW Biotechnol J; 2007 Sep; 2(9):1121-8. PubMed ID: 17703485 [TBL] [Abstract][Full Text] [Related]
29. Neurotechnology and Society: Strengthening Responsible Innovation in Brain Science. Garden H; Bowman DM; Haesler S; Winickoff DE Neuron; 2016 Nov; 92(3):642-646. PubMed ID: 27810009 [TBL] [Abstract][Full Text] [Related]
30. Should we make a fuss? A case for social responsibility in science. Beckwith J; Huang F Nat Biotechnol; 2005 Dec; 23(12):1479-80. PubMed ID: 16333283 [TBL] [Abstract][Full Text] [Related]
31. Use of animals in research: a science - society controversy? The European perspective. Van Zutphen LF ALTEX; 2002; 19(3):140-4. PubMed ID: 12165817 [TBL] [Abstract][Full Text] [Related]
32. Can science survive in the modern age? Brooks H Science; 1971 Oct; 174(4004):21-30. PubMed ID: 17755684 [TBL] [Abstract][Full Text] [Related]
33. Public information and the ethical responsibility of the industry. Bieri F Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):491-6. PubMed ID: 7885074 [TBL] [Abstract][Full Text] [Related]
34. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany. Schrell A; Bauser H; Brunner H Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818 [TBL] [Abstract][Full Text] [Related]
35. Strategy and society: the link between competitive advantage and corporate social responsibility. Porter ME; Kramer MR Harv Bus Rev; 2006 Dec; 84(12):78-92, 163. PubMed ID: 17183795 [TBL] [Abstract][Full Text] [Related]
36. The science of stem cells: ethical, legal and social issues. Daar AS; Sheremeta L Exp Clin Transplant; 2003 Dec; 1(2):139-46. PubMed ID: 15859920 [TBL] [Abstract][Full Text] [Related]
37. [Designing Genopole, a new concept and actor for science, technology and innovation policy in France]. Branciard A Med Sci (Paris); 2009 May; 25 Spec No 2():9-12. PubMed ID: 19852085 [TBL] [Abstract][Full Text] [Related]
38. [Social perception of biotechnology: a new tool for decision making]. Muñoz E Rev Derecho Genoma Hum; 1999; (10):195-208. PubMed ID: 10822646 [TBL] [Abstract][Full Text] [Related]
39. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Fears R; Kaufmann S; Ter Meulen V; Zumla A; Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566 [TBL] [Abstract][Full Text] [Related]